Four people with direct experience in the problem — a former clinical research coordinator, a health informatics engineer, a CRO operations manager, and a clinical NLP researcher — working together to remove the eligibility screening bottleneck from mid-size CROs.
CEO & Co-Founder
Spent four years as a clinical research coordinator and study manager at Duke Health's oncology trials unit in Durham, running multi-site Phase II-III trials and directly managing the manual screening bottleneck he founded Cohortbridge to solve.
CTO & Co-Founder
Health informatics engineer at Cerner Corporation for five years, building FHIR API integrations and clinical decision support pipelines for mid-size health systems across the Southeast before transitioning to early-stage health tech.
Head of Trial Operations
10 years of CRO project management experience at a regional CRO based in Research Triangle Park, having managed 18 multi-site trials across oncology and rare disease indications.
Clinical NLP Scientist
PhD in biomedical informatics at UNC Chapel Hill focused on clinical note extraction for oncology eligibility, with a postdoc at the RTI International health analytics division.
We’re a small team and we do our own demos. If you manage clinical trial operations at a mid-size CRO and want to see what the two-pass model looks like in practice, we’d like to talk.